• Firms strategically expand patent portfolios and deploy defensive licensing to avert hold-up and exploitation of valuable technologies in fragmented markets, shaping access and bargaining power [1], [7], [6], [5].

• Patents are treated as economic signals and policy instruments; researchers quantify patent quality and its link to R&D productivity, Bayh–Dole effects, and innovation incentives using multi-indicator approaches [4], [10], [18], [20].

• Global and regional IP systems affect access to medicines and technology diffusion, analyzing TRIPS-era reforms, grant lags, and harmonization tensions across Europe, China, India, and developing countries [8], [15], [13], [19], [20].

• Prosecution process dynamics, including examination duration and grant lags, reveal how agency capacity, workload, and institutional design shape patenting speed and strategic timing of filings [16], [13], [19].

• Enforcement and litigation shape firm strategies alongside prosecution; models and empirical work examine settlement choices, endogenous disputes, damages, and strategic use of litigation as a complement to patent rights [3], [5], [12], [14], [7].